Patient Registry for Berinert®, a C1-Esterase Inhibitor

Trial Profile

Patient Registry for Berinert®, a C1-Esterase Inhibitor

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Complement C1 inhibitor protein (Primary)
  • Indications Hereditary angioedema
  • Focus Adverse reactions
  • Sponsors CSL Behring
  • Most Recent Events

    • 04 Oct 2016 Results from older adult (aged >/=65 years) population (n=27) published in the Drugs and Aging.
    • 17 Mar 2016 New trial record
    • 07 Mar 2016 Results of 27 elderly subjects were presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top